Pharmaceutical Prices in the 21st Century, Zaheer-Ud-Din Babar
Автор: Zaheer-Ud-Din Babar Название: Pharmaceutical Prices in the 21st Century ISBN: 3319121685 ISBN-13(EAN): 9783319121680 Издательство: Springer Рейтинг: Цена: 18167.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: This book provides an overview of the global pharmaceutical pricing policies. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.
Описание: Isabell Koinig examines how a standardized promotional message for afictitious over-the-counter (OTC) medication is perceived by consumers in fourdifferent countries (Austria, Germany, the U.S., and Brazil), and the degree towhich it contributes to their self-empowerment.
Описание: This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug’s patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies.
Автор: Hassan Qudrat-Ullah; Peter Tsasis Название: Innovative Healthcare Systems for the 21st Century ISBN: 3319557734 ISBN-13(EAN): 9783319557731 Издательство: Springer Рейтинг: Цена: 18167.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Chapter1. Innovative Healthcare Systems: An Introduction.- Chapter2. Innovative Healthcare Applications of ICT for Developing Countries.- Chapter3. Transdisciplinary Approach to Design of a Total Healing Environment.- Chapter4. Systemic Development of Health Organizations: An Integrative Systems Methodology.- Chapter5. Centralizing Health Policies in an Age of Global Migration Flows.- Chapter6. Solar system design for water treatment: Anti Bacterial heat exchanger.- Chapter7. Modeling to Inform Long Term Care Policy and Planning for an Aging Society.- Chapter8. Framing Caesarean Section reduction policies through a Dynamic Performance Management approach: a Maternity Pathway case-based analysis.- Chapter9. "Epimemetic" Landscape- Relationship of Organizational Culture, Performance and Compliance vs Engagement.- Chapter10. Big Data Analytics in Healthcare Internet of Things.- Chapter11. Status and Challenges on Adaptation for Indian Healthcare Services with Data Mining Technique.- Chapter12. High Performance HR Practices in Healthcare in Canada.- Chapter13. Afterword: Moving Forward in Healthcare Systems in the 21st Century.
From Nobel Prize-winning economist Michael Kremer and fellow leading development economist Rachel Glennerster, an innovative solution for providing vaccines in poor countries
Millions of people in the third world die from diseases that are rare in the first world--diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world's poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices.
In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: "Pull" programs to stimulate research. Here's how such programs would work. Funding agencies would commit to purchase viable vaccines if and when they were developed. This would create the incentives for vaccine developers to produce usable products for these neglected diseases. Private firms, rather than funding agencies, would pick which research strategies to pursue. After purchasing the vaccine, funders could distribute it at little or no cost to the afflicted countries.
Strong Medicine details just how these legally binding commitments would work. Ultimately, if no vaccines were developed, such a commitment would cost nothing. But if vaccines were developed, the program would save millions of lives and would be among the world's most cost-effective health interventions.
Автор: Oliver Gassmann; Alexander Schuhmacher; Max von Ze Название: Leading Pharmaceutical Innovation ISBN: 3319668323 ISBN-13(EAN): 9783319668321 Издательство: Springer Рейтинг: Цена: 10480.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade.
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru
